Suvarna Garge (Editor)

Hybridon

Updated on
Edit
Like
Comment
Share on FacebookTweet on TwitterShare on LinkedInShare on Reddit
Headquarters
  
Cambridge, Massachusetts, United States

Hybridon, Inc (Amex: HBY) was a biotechnology company based in Cambridge, Massachusetts, specializing in the discovery and development of novel therapeutics and diagnostics using synthetic DNA, that merged with Idera Pharmaceuticals in 2004.

Notable investors

According to a U.S. Securities and Exchange Commission filing of May 4, 1999 Hybridon had investors with 5% or more ownership including:

  • Abdullah bin Mahfouz, son of the more widely known Khalid bin Mahfouz (13/87%), along with the Bermuda-based Mahfouz proprietary Intercity Holdings (13.87%);
  • Yahia M. A. Laden (8.67%), half-brother of the more infamous Osama bin Laden;
  • Nicris Limited, directed by Yehia bin Laden, and represented by Magnin Dunand et Associées (8.59%)
  • Faisal Finance Switzerland, the first Islamic bank registered in Switzerland, and a fully owned subsidiary of Dar al-Maal al-Islami Trust, which was under investigation in 2007 by the U.S. Department of Justice in two separate terrorism financing probes. (6.58%).

    • References

    Hybridon Wikipedia
    (Text) CC BY-SA